Medicines, Poisons and Therapeutic Goods Amendment Regulation 2021 (No 2) (ACT)

The Australian Capital Territory has enacted the Medicines, Poisons and Therapeutic Goods Amendment Regulation 2021 (No 2) to amend the Medicines, Poisons and Therapeutic Goods Regulation 2008. This regulation seeks to make several changes to the existing framework for the regulation of medicines and poisons within the ACT, including the definition of certain terms, the scope of certain provisions, and the categories of prescribers and medicines to which certain provisions apply.

The primary legal issues addressed by the regulation include the clarification of definitions related to medicines, poisons, and therapeutic goods, as well as the expansion of the categories of prescribers and medicines to which certain provisions apply. Additionally, the regulation seeks to update the list of approved indications for certain medicines and to revise the list of controlled medicines that may be prescribed by designated prescribers.

The court's reasoning and outcome in relation to this regulation are not explicitly stated in the provided text. However, it can be inferred that the regulation was enacted in accordance with the legislative process outlined in the Medicines, Poisons and Therapeutic Goods Act 2008, and that it was subject to the appropriate notification and publication requirements. As such, the regulation is likely to be valid and enforceable within the ACT, subject to any challenges or objections that may be raised by affected parties.

No final orders are stated in the provided text. However, it can be assumed that the regulation will come into effect on the day after its notification, as specified in the commencement provision. Additionally, the regulation may be subject to review or amendment in the future, in light of changing circumstances or new information.